NON-SMALL CELL LUNG
Clinical trials for NON-SMALL CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lung cancer patients whose tumors outsmart standard therapy
Disease control OngoingThis study tests whether adding savolitinib to osimertinib can help people with a specific type of advanced lung cancer (EGFR-mutated, MET-positive) whose cancer has worsened despite osimertinib treatment. About 345 adults will be randomly assigned to receive either the drug comb…
Matched conditions: NON-SMALL CELL LUNG
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 08:57 UTC
-
Lung cancer drug under the microscope: how does lorlatinib perform outside clinical trials?
Knowledge-focused OngoingThis study looks at how well the lung cancer medicine lorlatinib works when used as the first treatment for people with a specific type of advanced lung cancer (ALK-positive non-small cell lung cancer). Researchers will review medical records from a U.S. database to track how lon…
Matched conditions: NON-SMALL CELL LUNG
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 19, 2026 11:59 UTC